SA
GILD icon

Sicart Associates’s Gilead Sciences GILD Stock Holding History

Sicart Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,310
Closed -$11.4M – 73
2025
Q1 		$11.4M Sell
101,310
-4,620
-4% -$477K 3.93% 4
2024
Q4 		$9.78M Sell
105,930
-4,200
-4% -$378K 3.5% 6
2024
Q3 		$9.23M Hold
110,130
– – 3.24% 6
2024
Q2 		$7.56M Sell
110,130
-1,840
-2% -$123K 2.9% 12
2024
Q1 		$8.2M Sell
111,970
-1,690
-1% -$130K 3% 12
2023
Q4 		$9.21M Sell
113,660
-1,505
-1% -$117K 3.52% 8
2023
Q3 		$8.63M Sell
115,165
-175
-0.2% -$13.5K 3.38% 10
2023
Q2 		$8.89M Sell
115,340
-6,305
-5% -$503K 3.45% 7
2023
Q1 		$10.1M Sell
121,645
-21,850
-15% -$1.81M 3.92% 5
2022
Q4 		$12.3M Sell
143,495
-1,855
-1% -$147K 4.34% 5
2022
Q3 		$8.97M Sell
145,350
-24,550
-14% -$1.55M 3.18% 10
2022
Q2 		$10.5M Sell
169,900
-785
-0.5% -$48.6K 3.27% 9
2022
Q1 		$10.1M Sell
170,685
-15,455
-8% -$988K 2.63% 12
2021
Q4 		$13.7M Sell
186,140
-380
-0.2% -$26.2K 3.56% 10
2021
Q3 		$13M Sell
186,520
-6,920
-4% -$486K 3.55% 7
2021
Q2 		$13.3M Sell
193,440
-1,360
-0.7% -$90.8K 3.17% 11
2021
Q1 		$12.6M Buy
194,800
+2,900
+2% +$187K 3.33% 11
2020
Q4 		$11.2M Buy
191,900
+131,410
+217% +$7.93M 2.76% 13
2020
Q3 		$3.82M Buy
+60,490
New +$4.19M 1.14% 28

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sicart Associates's GILD Position: Q2 2025 in Review

Sicart Associates sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 101,310 shares — an estimated $11.4M sold.

Sicart Associates first reported a position in GILD in Q3 2020 and held it in 19 quarters. The position peaked at $13.7M in Q4 2021. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Sicart Associates reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Sicart Associates sold 101,310 Gilead Sciences shares in Q2 2025, an estimated $11.4M.
  • Sicart Associates first reported a position in Gilead Sciences in Q3 2020 and held it in 19 quarters.
  • Sicart Associates's Gilead Sciences position peaked at $13.7M in Q4 2021.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Sicart Associates's 13F filing for Q2 2025, filed 18 Jul 2025.